Halozyme Therapeutics, Inc.
HALO
$74.93
$1.532.08%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -26.71% | 25.47% | -10.54% | 25.95% | 14.15% |
Total Receivables | 3.85% | -1.24% | 7.95% | 33.20% | 9.51% |
Inventory | 10.09% | 16.22% | 7.95% | -17.51% | -5.48% |
Prepaid Expenses | 71.80% | 14.55% | -10.49% | -48.76% | 85.89% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -11.04% | 16.28% | -3.69% | 14.09% | 13.07% |
|
|||||
Total Current Assets | -11.04% | 16.28% | -3.69% | 14.09% | 13.07% |
Net Property, Plant & Equipment | -1.78% | -2.96% | 0.73% | -0.68% | -3.93% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -4.62% | -4.42% | -4.23% | -4.06% | -3.90% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 25.95% | -28.01% | 5.36% | 52.72% | 192.62% |
Total Assets | -6.49% | 6.45% | -2.58% | 7.54% | 6.95% |
|
|||||
Total Accounts Payable | -6.89% | 95.86% | -17.33% | -19.65% | 15.80% |
Total Accrued Expenses | -11.29% | 6.98% | 26.33% | 110.26% | -21.93% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -72.06% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 21.86% |
Total Other Current Liabilities | -- | -- | -- | -- | 21.86% |
Total Current Liabilities | -10.70% | 8.11% | 27.83% | -18.41% | 1.31% |
|
|||||
Total Current Liabilities | -10.70% | 8.11% | 27.83% | -18.41% | 1.31% |
Long-Term Debt | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -1.43% | 24.25% | -23.09% | 0.81% | -2.22% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 80.42% | -13.05% | 43.98% | 58.30% | -- |
Total Liabilities | 0.40% | 0.86% | 2.06% | -0.88% | 0.98% |
|
|||||
Common Stock & APIC | -98.47% | 6,175.61% | -99.80% | 100.86% | 158.99% |
Retained Earnings | -24.46% | 32.82% | -9.50% | 52.57% | 55.71% |
Treasury Stock & Other | -732.20% | -189.14% | 155.18% | -235.54% | -39.17% |
Total Common Equity | -31.00% | 32.56% | -19.63% | 56.42% | 62.77% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -31.00% | 32.56% | -19.63% | 56.42% | 62.77% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -31.00% | 32.56% | -19.63% | 56.42% | 62.77% |
|